US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL

Authors

Geoffrey L. Uy, Washington University School of Medicine in St. Louis

Journal

Blood Advances

Publication Date

2016

Volume

1

Issue

3

Inclusive Pages

250-259

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2016001495

Rights and Permissions

Ravandi, F., Othus, M., O'Brien, S. M., Forman, S. J., Ha, C. S., Wong, J. Y., Tallman, M. S., Paietta, E., Racevskis, J., Uy, G. L., Horowitz, M., Takebe, N., Little, R., Borate, U., Kebriaei, P., Kingsbury, L., Kantarjian, H. M., Radich, J. P., Erba, H. P., & Appelbaum, F. R. (2016). US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL. Blood Advances, 1(3), 250-259. https://doi.org/10.1182/bloodadvances.2016001495.

Recommended Citation

Uy, Geoffrey L., "US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL." Blood Advances. 1, 3. 250-259. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/7228